Join
Live feed
·
PRReleasevia Quantisnow
Enanta Pharmaceuticals Inc. logo

Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV)

ByQuantisnow·Wall Street's wire, on your screen.
ENTA· Enanta Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENTA (Enanta Pharmaceuticals Inc.) and more on Quantisnow.